Whether its for peak performance, faster recovery, or long-term wellness, they trust us to help them stay at their best
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
If you are still deciding how long to stay on, MOTS-c cycle length covers how long to run it, when to break, and what changes on a second cycle
After opening, it is commonly used for 28 days in laboratory practice
Buy Now Choose Your Bundle Select your multi-pack configuration of 3 ml or 10 ml sterile vials below